The first biopharma initial public offering (IPO) to take place on a European exchange in 2014 was also the biggest. Oxford, UK-based Circassia Pharmaceuticals plc raised £202 million (US$313.2 million) on March 13, which set a benchmark that was not beaten on either side of the Atlantic.